NanJing Pharmaceutical (SHSE:600713) Might Be Having Difficulty Using Its Capital Effectively

Simply Wall StOct 28, 2024 18:29 ET

Despite Delivering Investors Losses of 9.7% Over the Past 1 Year, NanJing Pharmaceutical (SHSE:600713) Has Been Growing Its Earnings

Simply Wall StSep 26, 2024 01:47 ET

Aidea Pharma Pledges Subsidiary's 51% Stake for 90 Million Yuan Loan; Shares Drop 5%

MT NewswiresSep 18, 2024 01:14 ET

Nanjing Pharmaceutical Issues 500 Million Yuan Ultra-Short-Term Bonds

MT NewswiresMay 28, 2024 02:46 ET

NanJing Medical Plans to Issue Up to 6 Billion Yuan in Ultra Short-Term Bonds

MT NewswiresApr 8, 2024 04:57 ET

NanJing Pharmaceutical's (SHSE:600713) Five-year Earnings Growth Trails the Notable Shareholder Returns

Simply Wall StDec 13, 2023 17:17 ET